J&J, Distributors Finalize $26B Landmark Opioid Settlement February 28, 2022 By Geoff Mulvihill CAMDEN, N.J. (AP) Drugmaker Johnson & Johnson and three major distributors finalized nationwide settlements over their role in the opioid...
Judge Greenlights J&J Strategy to Resolve Talc Lawsuits in Bankruptcy Court February 28, 2022 By Dietrich Knauth and Tom Hals Johnson & Johnson can use the bankruptcy system to resolve multibillion-dollar litigation claiming its talc products cause cancer, a U.S....
J&J Starts Trial on Bankruptcy Case Under Attack by Congress February 16, 2022 By Steven Church The controversial Johnson & Johnson bankruptcy strategy that’s drawn the ire of Congress faces a fresh trial this week, with...
Nevada to Join $26B Opioid Settlement With Drug Distributors, J&J January 5, 2022 By Nate Raymond Nevada has agreed to back a proposed nationwide settlement worth up to $26 billion resolving lawsuits against three large drug...
Johnson & Johnson to Stop Selling Talc-Based Baby Powder in U.S. and Canada May 20, 2020 By Carl O'Donnell Johnson & Johnson on Tuesday announced that it would stop selling its talc-based Johnson’s Baby Powder in the United States...
J&J Ordered by Jury to Pay $9 Million in Talc-Cancer Case February 28, 2020 By Jef Feeley Johnson & Johnson was ordered by a Florida jury to pay $9 million to an 82-year-old woman who blamed asbestos-tainted...
FDA to Hold Public Meeting on Testing for Asbestos In Talc February 4, 2020 By Chad Terhune and Lisa Girion SILVER SPRING, Md., — For the first time in nearly 50 years, the U.S. Food and Drug Administration will examine...
J&J Ordered to Pay $344 Million Over Vaginal-Mesh Marketing January 30, 2020 By Jef Feeley and Bill Callahan Johnson & Johnson was ordered to pay $344 million for misrepresenting the risks of vaginal-mesh implants to consumers in California,...
Study Casts Doubt That Baby Powder Use Raises Risks of Ovarian Cancer January 7, 2020 By Robert Langreth and Jef Feeley A study of more than 250,000 women found that those who used talc or other personal-hygiene powders weren’t significantly more...
J&J CEO Spurns U.S. Congressional Hearing on Carcinogens in Talc Products December 10, 2019 By Lisa Girion and Carl O'Donnell Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday...